Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
1.
Anal Cell Pathol (Amst) ; 2018: 8941908, 2018.
Article in English | MEDLINE | ID: mdl-29854577

ABSTRACT

Our previous findings showed a good therapeutic effect of the combination of suicide gene HSV-TK, nuclide 131I, and magnetic fluid hyperthermia (MFH) on hepatoma by using magnetic nanoparticles as linkers, far better than any monotherapy involved, with no adverse effects. This combination therapy might be an eligible strategy to treat hepatic cancer. However, it is not clear how the combination regimen took the therapeutic effects. In the current study, to explore the possible mechanisms of radionuclide-gene therapy combined with MFH to treat hepatoma at tissue, cellular, and molecular levels and to provide theoretical and experimental data for its clinical application, we examined the apoptosis induction of the combination therapy and investigated the expression of the proteins related to apoptosis such as survivin, livin, bcl-2, p53, and nucleus protein Ki67 involved in cell proliferation, detected VEGF, and MVD involved in angiogenesis of tumor tissues and analyzed the pathologic changes after treatment. The results showed that the combination therapy significantly induced the hepatoma cell apoptosis. The expression of survivin, VEGF, bcl-2, p53, livin, Ki67, and VEGF proteins and microvascular density (MVD) were all decreased after treatment. The therapeutic mechanisms may be involved in the downregulation of Ki67 expression leading to tumor cell proliferation repression and inhibition of survivin, bcl-2, p53, and livin protein expression inducing tumor cell apoptosis, negatively regulating VEGF protein expression, and reducing vascular endothelial cells, which results in tumor angiogenesis inhibition and microvascular density decrease and tumor cell necrosis. These findings offer another basic data support and theoretical foundation for the clinical application of the combination therapy.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Carcinoma, Hepatocellular/therapy , Ganciclovir/therapeutic use , Hyperthermia, Induced , Iodine Radioisotopes/chemistry , Liver Neoplasms/therapy , Nanospheres/chemistry , Thymidine Kinase/metabolism , Antibodies, Monoclonal/pharmacology , Apoptosis/drug effects , Carcinoma, Hepatocellular/blood supply , Carcinoma, Hepatocellular/pathology , Carcinoma, Hepatocellular/ultrastructure , Cell Proliferation/drug effects , Ganciclovir/pharmacology , Hep G2 Cells , Humans , Inhibitor of Apoptosis Proteins/metabolism , Liver Neoplasms/blood supply , Liver Neoplasms/pathology , Liver Neoplasms/ultrastructure , Microvessels/drug effects , Microvessels/pathology , Necrosis , Neoplasm Proteins/metabolism , Neovascularization, Pathologic/drug therapy , Neovascularization, Pathologic/pathology , Simplexvirus/metabolism , Survivin , Xenograft Model Antitumor Assays
2.
Sci Rep ; 6: 33524, 2016 09 19.
Article in English | MEDLINE | ID: mdl-27642033

ABSTRACT

Combination targeted therapy is a promising cancer therapeutic strategy. Here, using PEI-Mn0.5Zn0.5Fe2O4 nanoparticles (PEI-MZF-NPs) as magnetic media for MFH (magnetic fluid hyperthermia) and gene transfer vector for gene-therapy, a combined therapy, pHRE-Egr1-HSV-TK/(131)I-antiAFPMcAb-GCV/MFH, for hepatoma is developed. AntiAFPMcAb (Monoclonal antibody AFP) is exploited for targeting. The plasmids pHRE-Egr1-HSV-TK are achieved by incorporation of pEgr1-HSV-TK and pHRE-Egr1-EGFP. Restriction enzyme digestion and PCR confirm the recombinant plasmids pHRE-Egr1-HSV-TK are successfully constructed. After exposure to the magnetic field, PEI-MZF-NPs/pHRE-Egr1-EGFP fluid is warmed rapidly and then the temperature is maintained at 43 °C or so, which is quite appropriate for cancer treatment. The gene expression reaches the peak when treated with 200 µCi (131)I for 24 hours, indicating that the dose of 200 µCi might be the optimal dose for irradiation and 24 h irradiation later is the best time to initiate MFH. The in vitro and in vivo experiments demonstrate that pHRE-Egr1-HSV-TK/(131)I-antiAFPMcAb-GCV/MFH can greatly suppress hepatic tumor cell proliferation and induce cell apoptosis and necrosis and effectively inhibit the tumor growth, much better than any monotherapy does alone. Furthermore, the combination therapy has few or no adverse effects. It might be applicable as a strategy to treat hepatic cancer.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Carcinoma, Hepatocellular/therapy , Ganciclovir/therapeutic use , Hyperthermia, Induced , Liver Neoplasms/therapy , Nanotechnology , Simplexvirus/metabolism , Thymidine Kinase/metabolism , Apoptosis/drug effects , Carcinoma, Hepatocellular/blood , Carcinoma, Hepatocellular/pathology , Carcinoma, Hepatocellular/ultrastructure , Cell Proliferation/drug effects , Combined Modality Therapy , Dose-Response Relationship, Radiation , Early Growth Response Protein 1/metabolism , Ganciclovir/pharmacology , Hep G2 Cells , Humans , Iodine Radioisotopes/therapeutic use , Liver Neoplasms/blood , Liver Neoplasms/pathology , Liver Neoplasms/ultrastructure , Magnetics , Nanoparticles/chemistry , Nanoparticles/ultrastructure , Necrosis , Plasmids/metabolism , Polyethyleneimine/chemistry , Restriction Mapping , Temperature , Xenograft Model Antitumor Assays
3.
J Ethnopharmacol ; 190: 1-12, 2016 Aug 22.
Article in English | MEDLINE | ID: mdl-27235019

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Shen-Ling-Bai-Zhu Powder (SLBZP) is a classic traditional Chinese medical formula that has been used for several decades in the treatment of patients with gastrointestinal malignancies. Whether SLBZP is best employed as single agent or adjunctive therapy has yet to be determined as does the mechanism whereby SLBZP exerts its anti-tumor effects. AIM OF THE STUDY: To investigate the effects of SLBZP alone and in combination with Cytoxan (CTX) on tumor growth, malignant cell apoptosis and Akt/Nuclear Factor kappa B (NF-КB) signaling in a murine model of hepatocellular carcinoma (HCC) receiving chemotherapy. MATERIALS AND METHODS: Sixty-four adult mice developed HCC following subcutaneous inoculation with H22 hepatocellular carcinoma cells. Seven days later, all received chemotherapy with CTX (200mg/kg) once. Mice were then randomized into eight study groups (N=8/group). Three groups were treated with different concentrations of SLBZP alone (6.00, 3.00, 1.5g/kg), three with SLBZP (6.00, 3.00, 1.5g/kg) plus CTX (20mg/kg), one with CTX (20mg/kg) alone (positive control), and one with physiologic saline (untreated, negative control). All groups were treated for 14 days. Tumor size, histology and serum or tissue levels and/or mRNA expression of PDGF-BB, VEGF, Ang-1, Ang-2, NF-КB, B-cell lymphoma-2 (Bcl-2); B-cell lymphoma-extra large (Bcl-xL); X-linked inhibitor of apoptosis (XIAP), Survivin, Caspase-3, Caspase-9, Caspase-7, Akt and phosphorylated Akt expression were documented at the end of treatment. RESULTS: Compared to untreated negative controls, tumor sizes were decreased in the CTX alone, SLBZP (M)+CTX and SLBZP (H)+CTX groups (-52%,-53% and -58% respectively). Tumor cell density was decreased in all treated groups but most apparent in the SLBZP (H)+CTX group. Electron microscopic evidence of apoptosis was also most apparent in this group. Serum and/or tissue levels and expression of PDGF-BB, VEGF, Ang-1, Ang-2, their downstream signaling proteins and anti-apoptotic markers were lowest and pro-apoptotic markers highest in SLBZP (H)+CTX treated mice. CONCLUSIONS: In this chemotherapy-induced animal model of HCC, SLBZP was most efficacious as adjunctive therapy and appears to act by inhibiting tumor growth promoters and anti-apoptotic proteins while enhancing pro-apoptotic proteins.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Antineoplastic Combined Chemotherapy Protocols/pharmacology , Apoptosis/drug effects , Carcinoma, Hepatocellular/drug therapy , Cisplatin/pharmacology , Drugs, Chinese Herbal/pharmacology , Liver Neoplasms, Experimental/drug therapy , Angiogenic Proteins/genetics , Angiogenic Proteins/metabolism , Animals , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/metabolism , Biomarkers, Tumor/genetics , Biomarkers, Tumor/metabolism , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/ultrastructure , Cell Line, Tumor , Dose-Response Relationship, Drug , Female , Gene Expression Regulation, Neoplastic , Liver Neoplasms, Experimental/genetics , Liver Neoplasms, Experimental/metabolism , Liver Neoplasms, Experimental/ultrastructure , Male , Mice , RNA, Messenger/genetics , RNA, Messenger/metabolism , Signal Transduction/drug effects , Time Factors , Tumor Burden/drug effects
4.
Pharm Biol ; 54(8): 1445-57, 2016 Aug.
Article in English | MEDLINE | ID: mdl-26810384

ABSTRACT

Context 2a,-3a,-24-Trihydroxyurs-12-en-28-oic acid (TEO, a corosolic acid analogue) is a triterpenoid saponin isolated from Actinidia valvata Dunn (Actinidiaceae), a well-known traditional Chinese medicine. Objective This study investigated the anti-proliferation and inducing apoptosis effects of TEO in three human hepatocellular carcinoma (HCC) cell lines. Materials and methods Cytotoxic activity of TEO was determined by the MTT assay at various concentrations from 2.5 to 40 µg/mL in BEL-7402, BEL-7404 and SMMC-7721 cell lines. Cell morphology was assessed by acridine orange/ethidium bromide and 4'-6-diamidino-2-phenylindole dihydrochloride staining and fluorescence microscopy. Cell-cycle distribution and DNA damage were determined by flow cytometry and comet assay. Mitochondrial dysfunction was assessed by JC-1 staining and transmission electron microscopy. Apoptosis changes were explored by Western blot, TNF-α and caspase-3, -8, -9 assays. Results TEO exhibited inhibition effects on BEL-7402, BEL-7404 and SMMC-7721 cells treated for 24 h, the IC50 values were 34.6, 30.8 and 30.5 µg/mL, respectively. TEO (40 µg/mL)-treated three cell lines increased by more than 21% in the G1 phase and presented the morphological change and DNA damage. TEO also declined the mitochondrial membrane potential and altered mitochondrial ultra-structure. Furthermore, caspase-3, caspase-8, caspase-9 and TNF-α were also activated. Mechanism investigation showed that TEO could decrease anti-apoptotic Bcl-2 protein expression, increase proapoptotic Bax and Bid proteins expressions and increase Bax/Bcl-2 ratio. Conclusion Our results demonstrate for the first time that TEO inhibited growth of HCC cell lines and induced G1 phase arrest. Moreover, proapoptotic effects of TEO were mediated through the activation of TNF-α, caspases and mitochondrial pathway.


Subject(s)
Actinidia , Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , Carcinoma, Hepatocellular/drug therapy , Liver Neoplasms/drug therapy , Mitochondria, Liver/drug effects , Plant Extracts/pharmacology , Triterpenes/pharmacology , Actinidia/chemistry , Apoptosis Regulatory Proteins/metabolism , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/ultrastructure , Cell Line, Tumor , Cell Shape/drug effects , DNA Damage , Dose-Response Relationship, Drug , G1 Phase Cell Cycle Checkpoints/drug effects , Humans , Inhibitory Concentration 50 , Liver Neoplasms/metabolism , Liver Neoplasms/ultrastructure , Membrane Potential, Mitochondrial/drug effects , Mitochondria, Liver/metabolism , Mitochondria, Liver/ultrastructure , Phytotherapy , Plant Extracts/isolation & purification , Plants, Medicinal , Signal Transduction/drug effects , Time Factors , Triterpenes/isolation & purification , Tumor Necrosis Factor-alpha/metabolism
5.
Chin J Integr Med ; 22(5): 362-9, 2016 May.
Article in English | MEDLINE | ID: mdl-26383159

ABSTRACT

OBJECTIVE: To investigate the anti-cancer effects of crude extract from Melia toosendan Sieb. et Zucc and its possible molecular mechanisms in vitro and in vivo. METHODS: Transonic alcohol-chloroform extraction method was used to extract toosendanin from the bark of Melia toosendan Sieb. et Zucc, and the content of toosendanin in the crude extract was measured by high performance liquid chromatography (HPLC). Anti-cancer effects of crude extract from Melia toosendan Sieb. et Zucc were investigated in in vivo and in vitro studies. In the in vitro experiment, human hepatocellular carcinoma cell lines SMMC-7721 and Hep3B were co-incubated with toosendanin crude extract of different concentrations, respectively. In the in vivo experiment, BALB/c mice were subcutaneously inoculated with mouse hepatocellular carcinoma H22 cells and treated with crude extract. RESULTS: HPLC revealed the content of toosendanin was about 15%. Crude extract from Melia toosendan Sieb. et Zucc inhibited cancer cells growth in a dose- and time-dependent manner. The 50% inhibitory concentration (IC50, 72 h) was 0.6 mg/L for SMMC-7721 cells and 0.8 mg/L for Hep3B cells. Both high-dose [0.69 mg/(kg d)] and low-dose [0.138 mg/(kg d)] crude extract could markedly suppress cancer growth, and the inhibition rate was greater than 50%. Hematoxylin and eosin staining showed necrotic area in cancers and transmission electron microscopy displayed necrotic and apoptotic cancer cells with apoptotic bodies. Immunohistochemistry showed that the expression of Bax and Fas increased and the expression of Bcl-2 reduced. CONCLUSIONS: Toosendanin extract has potent anti-cancer effects via suppressing proliferation and inducing apoptosis of cancer cells in vivo and in vitro. The mechanism of apoptosis involves in mitochondrial pathway and death receptor pathway.


Subject(s)
Antineoplastic Agents/therapeutic use , Carcinoma, Hepatocellular/drug therapy , Drugs, Chinese Herbal/therapeutic use , Liver Neoplasms/drug therapy , Melia/chemistry , Plant Extracts/therapeutic use , Animals , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Carcinoma, Hepatocellular/pathology , Carcinoma, Hepatocellular/ultrastructure , Cell Proliferation/drug effects , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/pharmacology , Female , Immunohistochemistry , Liver Neoplasms/pathology , Liver Neoplasms/ultrastructure , Male , Mice, Inbred BALB C , Mitochondria/drug effects , Mitochondria/metabolism , Neoplasm Transplantation , Reference Standards , bcl-2-Associated X Protein/metabolism , fas Receptor/metabolism
6.
Food Chem Toxicol ; 83: 183-92, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26116884

ABSTRACT

In this study, we examined the mechanism underlying the effect of Saururus chinensis Baill (saururaceae) on hepatocellular carcinoma HepG2 cells. HepG2 cells and Chang cells were exposed to various concentrations of S. chinensis Baill extract (SC-E) for 24 h. SC-E affected more significantly HepG2 cells than Chang cells in terms of cell viability and ATP production. Therefore, current study examined detailed mechanism how SC-E affected HepG2 cell survival. We found that SC-E (75 and 150 µg/ml) induced apoptosis via oxidative stress. SC-E also caused CCAAT-enhancer-binding protein homologous protein (CHOP) activation by dissociating the binding immunoglobulin protein (BiP) from inositol-requiring 1α (IRE1α) in the endoplasmic reticulum (ER) and induced Bax, cytochrome c release to cytosol, caspase-3 activation, and poly ADP ribose polymerase (PARP) cleavage, resulting in HepG2 cell apoptosis. Furthermore, SC-E caused ER Ca(2+) leakage into the cytosol; ER dilation and mitochondrial membrane damage were observed in transmission electron microscopy (TEM). Taken together, our results demonstrated that SC-E induced cancer cell apoptosis specifically through ER stress.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , Carcinoma, Hepatocellular/drug therapy , Endoplasmic Reticulum Stress/drug effects , Liver Neoplasms/drug therapy , Plant Extracts/pharmacology , Saururaceae/chemistry , Antineoplastic Agents, Phytogenic/adverse effects , Calcium Signaling/drug effects , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/ultrastructure , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cell Nucleus/ultrastructure , Cell Survival/drug effects , Endoplasmic Reticulum/drug effects , Endoplasmic Reticulum/metabolism , Endoplasmic Reticulum/ultrastructure , Energy Metabolism/drug effects , Hep G2 Cells , Hepatocytes/drug effects , Humans , Liver Neoplasms/metabolism , Liver Neoplasms/ultrastructure , Medicine, East Asian Traditional , Microscopy, Electron, Transmission , Mitochondrial Membranes/drug effects , Mitochondrial Membranes/metabolism , Mitochondrial Membranes/ultrastructure , Oxidative Stress/drug effects , Plant Extracts/adverse effects , Republic of Korea
7.
Biomed Res Int ; 2014: 682197, 2014.
Article in English | MEDLINE | ID: mdl-25110686

ABSTRACT

AIM: Rosin, the traditional Chinese medicine, is reported to be able to inhibit skin cancer cell lines. In this report, we investigate the inhibitory effect against HCC cells of QC2, the derivative of rosin's main components dehydroabietic acid. METHODS: MTT assay was used to determine the cytotoxicity of QC2. Morphological changes were observed by time-lapse microscopy and transmission electron microscopy and the cytoskeleton changes were observed by laser-scanning confocal microscopy. Cytomembrane integrity and organelles damage were confirmed by detection of the reactive oxygen (ROS), lactate dehydrogenase (LDH), and mitochondrial membrane potential (Δψm). The underlying mechanism was manifested by Western blotting. The oncotic cell death was further confirmed by detection of oncosis related protein calpain. RESULTS: Swelling cell type and destroyed cytoskeleton were observed in QC2-treated HCC cells. Organelle damage was visualized by transmission electron microscopy. The detection of ROS accumulation, increased LDH release, and decreased ATP and Δψm confirmed the cell death. The oncotic related protein calpain was found to increase time-dependently in QC2-treated HCC cells, while its inhibitor PD150606 attenuated the cytotoxicity. CONCLUSIONS: Dehydroabietic acid derivative QC2 activated oncosis related protein calpain to induce the damage of cytomembrane and organelles which finally lead to oncosis in HCC cells.


Subject(s)
Abietanes/pharmacology , Carcinoma, Hepatocellular/drug therapy , Carcinoma, Hepatocellular/pathology , Liver Neoplasms/drug therapy , Liver Neoplasms/pathology , Abietanes/chemical synthesis , Abietanes/chemistry , Adenosine Triphosphate/deficiency , Amino Acid Chloromethyl Ketones/pharmacology , Calpain/metabolism , Carcinoma, Hepatocellular/ultrastructure , Caspase 3/metabolism , Caspase Inhibitors/pharmacology , Cell Death/drug effects , Cell Line, Tumor , Cell Membrane/drug effects , Cell Membrane/metabolism , Cytoskeleton/drug effects , Cytoskeleton/ultrastructure , Hepatocytes/drug effects , Hepatocytes/pathology , Humans , Imidazoles/pharmacology , Indoles/pharmacology , Liver Neoplasms/ultrastructure , Membrane Potential, Mitochondrial/drug effects , Reactive Oxygen Species/metabolism
8.
Mater Sci Eng C Mater Biol Appl ; 36: 7-13, 2014 Mar 01.
Article in English | MEDLINE | ID: mdl-24433880

ABSTRACT

Tea polyphenols have strong antioxidant and antitumor activities. However, these health benefits are limited due to their poor in vivo stability and low bioavailability. Chitosan nanoparticles as delivery systems may provide an alternative approach for enhancing bioavailability of poorly absorbed drugs. In this study, tea polyphenol-loaded chitosan nanoparticles have been prepared using two different chitosan biomaterials, and their antitumor effects were evaluated in HepG2 cells, including cell cytotoxicity comparison, cell morphology analysis, cell apoptosis and cell cycle detection. The results indicated that the tea polyphenol-loaded chitosan nanoparticles showed a branch shape and heterogeneous distribution in prepared suspension. MTT assay suggested that tea polyphenol-loaded chitosan nanoparticles could inhibit the proliferation of HepG2 cells, and the cytotoxicity rates were increased gradually and appeared an obvious dose-dependent relationship. Transmission electron microscope images showed that the HepG2 cells treated with tea polyphenol-loaded chitosan nanoparticles exhibited some typical apoptotic features, such as microvilli disappearance, margination of nuclear chromatin, intracytoplasmic vacuoles and the mitochondrial swelling. In addition, the tea polyphenol-loaded chitosan nanoparticles had relatively weak inhibitory effects on HepG2 cancer cells compared with tea polyphenols. Tea polyphenols not only induced cancer cell apoptosis, but also promoted their necrosis. However, tea polyphenol-loaded chitosan nanoparticles exhibited their antitumor effects mainly through inducing cell apoptosis. Our results revealed that the inhibition effects of tea polyphenol-loaded chitosan nanoparticles on tumor cells probably depended on their controlled drug release and effective cell delivery. The chitosan nanoparticles themselves as the delivery carrier showed limited antitumor effects compared with their encapsulated drugs.


Subject(s)
Apoptosis/drug effects , Carcinoma, Hepatocellular/pathology , Chitosan/chemistry , Liver Neoplasms/pathology , Nanoparticles/toxicity , Polyphenols/pharmacology , Tea/chemistry , Carcinoma, Hepatocellular/ultrastructure , Cell Cycle/drug effects , Cell Nucleus/drug effects , Hep G2 Cells , Humans , Liver Neoplasms/ultrastructure , Nanoparticles/ultrastructure , Particle Size
9.
Int J Mol Sci ; 14(1): 1370-82, 2013 Jan 11.
Article in English | MEDLINE | ID: mdl-23344047

ABSTRACT

The traditional Chinese medicine bufalin, extracted from toad's skin, has been demonstrated to exert anticancer activities in various kinds of human cancers. The mechanisms of action lie in its capacity to induce apoptosis, or termed type I programmed cell death (PCD). However, type II PCD, or autophagy, participates in cancer proliferation, progression, and relapse, as well. Recent studies on autophagy seem to be controversial because of the dual roles of autophagy in cancer survival and death. In good agreement with previous studies, we found that 100 nM bufalin induced extensive HepG2 cell apoptosis. However, we also noticed bufalin triggered autophagy and enhanced Beclin-1 expression, LC3-I to LC3-II conversion, as well as decreased p62 expression and mTOR signaling activation in HepG2 cells. Blockage of autophagy by selective inhibitor 3-MA decreased apoptotic ratio in bufalin-treated HepG2 cells, suggesting a proapoptotic role of bufalin-induced autophagy. Furthermore, we investigated the underlying mechanisms of bufalin-induced autophagy. Bufalin treatment dose-dependently promoted AMPK phosphorylation while AMPK inhibition by compound C significantly attenuated bufalin-induced autophagy. Taken together, we report for the first time that bufalin induces HepG2 cells PCD, especially for autophagy, and the mechanism of action is, at least in part, AMPK-mTOR dependent.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Autophagy/drug effects , Bufanolides/pharmacology , AMP-Activated Protein Kinases/metabolism , Antineoplastic Agents/chemistry , Apoptosis Regulatory Proteins/metabolism , Beclin-1 , Blotting, Western , Bufanolides/chemistry , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/pathology , Carcinoma, Hepatocellular/ultrastructure , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Hep G2 Cells , Humans , Liver Neoplasms/metabolism , Liver Neoplasms/pathology , Liver Neoplasms/ultrastructure , Membrane Proteins/metabolism , Microscopy, Confocal , Microscopy, Electron, Transmission , Microtubule-Associated Proteins/metabolism , Molecular Structure , Phosphorylation/drug effects , Signal Transduction/drug effects , TOR Serine-Threonine Kinases/metabolism
10.
Chin J Integr Med ; 18(3): 203-8, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22466945

ABSTRACT

OBJECTIVE: To study the immunologic function of dendritic cells (DCs) cultured in two kinds of hepatoma cell line's supernatant and the enhancing effects of carboxymethylpachymaran (CMP) on DCs. METHODS: DCs were harvested after stimulation by granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-4 from umbilical cord blood using density-gradient centrifugation method. Cultured supernatant of two hepatoma cell lines (HepG2 and HepG2.2.15) were collected for condition medium (CM) according to a volume ratio of supernatant to incomplete RPMI-1640 medium, which was 3:1. CMP was dissolved in incomplete RPMI-1640 medium. Experimental groups were divided according to the culture medium, either CM or with CMP in it. DCs subsets CD83, CD86, CD1a, and d-related human leukocyte antigens (HLA-DR) were analyzed by flow cytometry. The proliferation ability of allogeneic T cells in mixed lymphocyte reaction (MLR) stimulated by DCs was examined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) analysis. IL-12p70, interferon-γ (IFN-γ), and nuclear factor κB (NF-κB) were detected by enzyme-linked immunosorbent assay analysis. RESULTS: The proliferation of lymphocytes and secreting level of IL-12 and expression of phenotype of DCs cultured in two kinds of CM were lower than those of normal group (P <0.01). Compared with the normal group, groups treated with CMP showed a higher expression level of DCs subsets, lymphocyte reproductive activity, as well as IL-12 and IFN-γ secretion levels. Groups treated with CMP also demonstrated higher levels of DCs phenotype expression and IL-12 and IFN-γ secretion in supernatant of MLR and higher lymphocyte reproductive activity compared with CM group (P <0.05). Compared with the normal group, the expression level of NF-κB in DCs nuclear was higher in CMP groups but lower in two CM groups (P <0.05). After CMP was added, the NF-κB expression levels of two CM groups were increased compared with levels before CMP was added (P <0.05). However, there was no significant difference between the two CM groups (P >0.05). CONCLUSIONS: Two kinds of hepatoma cell line's supernatant can inhibit the immunologic function of DCs. This suppressive effect may be related to the inhibition of NF-κB/Rel pathway. CMP may up-regulate the DCs function by activating the NF-κB/Rel pathway.


Subject(s)
Carcinoma, Hepatocellular/pathology , Dendritic Cells/drug effects , Dendritic Cells/immunology , Glucans/pharmacology , Liver Neoplasms/pathology , Signal Transduction/drug effects , Transcription Factor RelA/metabolism , Carcinoma, Hepatocellular/ultrastructure , Cell Line, Tumor , Cell Shape , Humans , Immunophenotyping , Interferon-gamma/metabolism , Interleukin-12/metabolism , Liver Neoplasms/ultrastructure , Lymphocyte Culture Test, Mixed , Subcellular Fractions/drug effects
11.
Yakugaku Zasshi ; 131(6): 993-1000, 2011.
Article in English | MEDLINE | ID: mdl-21628989

ABSTRACT

Panaxydol (PND) is one of the main non-peptidyl small molecules isolated from the lipophilic fractions of Panax notoginseng. The present study was carried out to demonstrate the potential effects of panaxydol on the induction of differentiation of human liver carcinoma cell lines SMMC-7721. Cell viability was evaluated by MTT method and Trypan blue exclusion assay respectively. The changes of morphology were detected by transmission electron microscope. Inhibitors were applied to detect the signaling pathway of differentiation. The level of intracellular cyclic AMP was determined by radioimmunoassay. The expression of p-ERK, Id1, and p21 were determined by Western blot. We found that panaxydol inhibit the proliferation of SMMC-7721 cells and caused the morphology and ultrastructure changes of SMMC-7721. Moreover, panaxydol dose-dependently increased the secretion of albumin and alkaline phosphatase activity, and decreased the secretion of AFP correspondingly. These changes of differentiation markers in SMMC-7721 can be reversed by the protein kinase A inhibitor RpcAMPS and by MAP kinase kinase 1/2 inhibitor U0126 or sorafenib. Intracellular cAMP was elevated by panaxydol in SMMC-7721 cells. Panaxydol dose-dependently decreased the expression of regulatory factors Id1 and increased the protein levels of p21 and p-ERK1/2 correspondingly. It suggested panaxydol might be of value for further exploration as a potential anti-cancer agent via cAMP and MAP kinase-dependent mechanism.


Subject(s)
Antineoplastic Agents/pharmacology , Carcinoma, Hepatocellular/pathology , Cell Differentiation/drug effects , Cyclic AMP/metabolism , Diynes/pharmacology , Extracellular Signal-Regulated MAP Kinases/metabolism , Fatty Alcohols/pharmacology , Liver Neoplasms/pathology , Antineoplastic Agents/isolation & purification , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/ultrastructure , Cell Proliferation/drug effects , Cell Survival/drug effects , Cyclic AMP/physiology , Depression, Chemical , Diynes/isolation & purification , Dose-Response Relationship, Drug , Drugs, Chinese Herbal/analysis , Extracellular Signal-Regulated MAP Kinases/physiology , Fatty Alcohols/isolation & purification , Humans , Liver Neoplasms/metabolism , Liver Neoplasms/ultrastructure , Microscopy, Electron, Transmission , Signal Transduction/drug effects , Tumor Cells, Cultured
12.
Int J Mol Med ; 27(4): 599-606, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21274505

ABSTRACT

Induction of autophagy usually acts as a survival mechanism of cancer cells in response to chemotherapy. However, the function and molecular mechanism of autophagy in human hepatoma cells under drug treatment is still not clear. To address this issue, we established an experimental model in which HepG2 cells were treated with etoposide, a widely used anticancer agent. We demonstrate the etoposide-induced accumulation of GFP-LC3 dots by fluorescent microscopy, the up-regulation of LC3-II protein expression by Western blotting and the increased number of autophagic vacuoles by electron microscopy, confirming the activation of autophagy by etoposide in HepG2 cells. Inhibition of autophagy by either 3-methyladenine (3MA) or beclin-1 small interfering RNA enhanced etoposide-induced cell death. Furthermore, activation of p53 and AMPK was detected in etoposide-treated cells and inhibition of AMPK triggered apoptosis through suppression of autophagy. On the other hand, inactivation of p53 promoted cell survival through augmentation of autophagy. Collectively, these findings indicate that etoposide-induced autophagy promotes hepatoma cell adaptation and survival, and that autophagy inhibition improves the chemotherapeutic effect of etoposide. Moreover, AMPK activation is clearly associated with etoposide-induced autophagy. We conclude that manipulation of AMPK may be a promising approach of adjuvant chemotherapy for hepatocellular carcinoma.


Subject(s)
Antineoplastic Agents/pharmacology , Autophagy/drug effects , Carcinoma, Hepatocellular/pathology , Etoposide/pharmacology , Liver Neoplasms/pathology , AMP-Activated Protein Kinases/metabolism , Adenine/analogs & derivatives , Adenine/pharmacology , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/metabolism , Beclin-1 , Carcinoma, Hepatocellular/ultrastructure , DNA Damage/drug effects , Gene Expression Regulation, Neoplastic/drug effects , Gene Expression Regulation, Neoplastic/genetics , Hep G2 Cells , Humans , Liver Neoplasms/ultrastructure , Membrane Proteins/genetics , Membrane Proteins/metabolism , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Signal Transduction , Tumor Suppressor Protein p53/metabolism
13.
Planta Med ; 74(3): 245-51, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18283616

ABSTRACT

Matrine is a component of the traditional Chinese medical herb Sophora flavescens Ait, which is widely used to treat diseases such as viral hepatitis, cardiac arrhythmia and skin inflammations. As indicated by previous reports, the molecular mechanism of matrine's anti-cancer effect has been poorly clarified. In this study, we used both in vitro and in vivo models to investigate matrine's antitumor effect and its possible molecular mechanisms. Murine hepatocellular carcinoma H22 cells were cultured in the presence of matrine at various concentrations (0.2 - 2.0 mg/mL). A dose-dependent antiproliferation effect was observed. The 50 % inhibitory concentration (IC (50)) was 0.6 mg/mL. Antiproliferation effects of matrine were associated with an increase in cells arrested in the G (1) phase of the cell cycle. Morphological changes, flow cytometric analysis and expression of the proapoptotic protein Bax indicated that this anticancer effect was mediated via apoptosis. In vivo antitumor efficacy was evaluated following S. C. inoculation of H22 cells in BALB/c mice. Matrine administrated I. P. resulted in strong in vivo anticancer activity. Our results showed that seven doses of matrine at 50 mg/kg/dose inhibited 60.7 % of tumor growth. Transmission electron microscope (TEM) analysis and histoimmunochemical staining for Bcl-2 and Bax proteins also indicated induction of apoptosis in tumor tissues by matrine. Taken together, our results demonstrate that matrine possesses strong antitumor activities in vitro and in vivo. Inhibition of cell proliferation and induction of apoptosis are the likely mechanisms responsible for matrine's antitumor activities.


Subject(s)
Alkaloids/therapeutic use , Apoptosis/drug effects , Carcinoma, Hepatocellular/drug therapy , Liver Neoplasms/drug therapy , Quinolizines/therapeutic use , Alkaloids/pharmacology , Animals , Antineoplastic Agents, Phytogenic/analysis , Carcinoma, Hepatocellular/ultrastructure , Cell Line, Tumor , Cell Proliferation/drug effects , Female , Liver Neoplasms/ultrastructure , Mice , Mice, Inbred BALB C , Microscopy, Electron, Transmission , Phytotherapy , Proto-Oncogene Proteins c-bcl-2/metabolism , Quinolizines/pharmacology , Sophora/chemistry , bcl-2-Associated X Protein/metabolism , Matrines
14.
Nan Fang Yi Ke Da Xue Xue Bao ; 26(7): 975-7, 2006 Jul.
Article in Chinese | MEDLINE | ID: mdl-16864090

ABSTRACT

OBJECTIVE: To observe the effects of Scutellaria barbata extract (ESB) on human hepatoma cell line Hep-G2 proliferation in vitro and explore the mechanism. METHODS: The inhibitory effect of ESB on Hep-G2 proliferation was estimated by MTT assay, and the morphological changes of the cells were observed under optical and electron microscopes. Distribution of cell cycle, cell apoptosis and the protein expressions of apoptosis-associated genes as bcl-2, bax and fas were analyzed using flow cytometry. RESULTS: ESB inhibited the proliferation of Hep-G2 cells in a time- and dose-dependent manner. ESB treatment for 72 h resulted in changes of early apoptotic morphology of the cells as observed under optical and the transmission electron microscopes and increased cell apoptosis. Cell cycle analysis revealed decreased S-phase and increased G0/G1-phase cells. Fas expression was significantly up-regulated in response to ESB treatment whereas Bcl-2 and Bax expressions underwent no significant changes. CONCLUSION: ESB can inhibit Hep-G2 cell proliferation, induce cell cycle block, and increase cell apoptosis, which may relate to the activation of FNFR superfamily.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Cell Proliferation/drug effects , Plant Extracts/pharmacology , Scutellaria/chemistry , Apoptosis/drug effects , Carcinoma, Hepatocellular/pathology , Carcinoma, Hepatocellular/physiopathology , Carcinoma, Hepatocellular/ultrastructure , Cell Cycle/drug effects , Cell Line, Tumor , Dose-Response Relationship, Drug , Drugs, Chinese Herbal/pharmacology , Flow Cytometry , Humans , Liver Neoplasms/pathology , Liver Neoplasms/physiopathology , Liver Neoplasms/ultrastructure , Microscopy, Electron, Transmission , Proto-Oncogene Proteins c-bcl-2/analysis , bcl-2-Associated X Protein/analysis , fas Receptor/analysis
15.
Nan Fang Yi Ke Da Xue Xue Bao ; 26(5): 591-3, 2006 May.
Article in Chinese | MEDLINE | ID: mdl-16762857

ABSTRACT

OBJECTIVE: To investigate the inhibition effect of Scutellariae barbata extracts on the proliferation of human hepatocellular carcinoma cell line QGY-7701. METHODS: The inhibition activity of the extracts against cell line QGY-7701 was estimated by MTT assay. Morphologic changes of the cells were observed under light microscope and electronic microscope. Cell cycle distribution, cell apoptosis and expressions of apoptosis-associated genes as Bcl-2, Bax and Fas were analyzed by flow cytometry. RESULTS: Extracts of Scutellariae barbata could inhibit the proliferation of QGY-7701. When treated with the extracts for 72 h, cells at the early stage of apoptosis showed morphologic changes, apoptotic cells increased, cells at G0/G1 phase decreased and those at G2/M phase increased, the expression of Bax significantly up-regulated and that of Bcl-2 down-regulated with no change in Fas gene. CONCLUSION: The extracts of Scutellariae barbata inhibit the proliferation of QGY-7701, which may relate to the activation of anti-oncogene Bcl-2, induction of cell apoptosis and inhibition of G to S phase cell cycle progress.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , Plant Extracts/pharmacology , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/pathology , Carcinoma, Hepatocellular/ultrastructure , Cell Cycle/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Drugs, Chinese Herbal/pharmacology , Flow Cytometry , Humans , Liver Neoplasms/metabolism , Liver Neoplasms/pathology , Liver Neoplasms/ultrastructure , Microscopy, Electron, Transmission , Proto-Oncogene Proteins c-bcl-2/metabolism , Scutellaria baicalensis , bcl-2-Associated X Protein/metabolism , fas Receptor/metabolism
16.
Zhong Xi Yi Jie He Xue Bao ; 2(5): 372-4, 2004 Sep.
Article in Chinese | MEDLINE | ID: mdl-15383263

ABSTRACT

OBJECTIVE: To study the feasibility of the establishment of the orthotopic transplantation tumor model of hepatocellular carcinoma in mice and its tumor biological characteristics. METHODS: H22 cells of hepatocellular carcinoma were inoculated to form ectopic transplanted model in mice by subcutaneous injection. Then the subcutaneous tumors were implanted into the liver of mice, and the orthotopic transplantation tumor model of hepatocellular carcinoma was established. RESULTS: The successful rate of the orthotopic transplantation tumor model was 95.6% and the spontaneous metastatic rate was 81.8%, the rate of mass ascites was 40.9% and the natural extinctive rate was 0%. The natural survival time in the orthotopic transplantation tumor model was 28 days and the proliferation of tumor in transplanted model was accelerated after 2 weeks or so. CONCLUSION: The orthotopic transplantation tumor model in mice is an ideal model for studying the metastatic mechanism and screening anti-tumor drugs for liver cancer, just because of its high successful rate and high spontaneous metastatic rate with no natural extinction.


Subject(s)
Carcinoma, Hepatocellular/pathology , Disease Models, Animal , Liver Neoplasms, Experimental/pathology , Animals , Carcinoma, Hepatocellular/ultrastructure , Cell Line, Tumor , Injections, Subcutaneous , Liver Neoplasms, Experimental/ultrastructure , Male , Mice , Mice, Inbred ICR , Microscopy, Electron , Neoplasm Metastasis , Neoplasm Transplantation/methods
17.
Acta Pharmacol Sin ; 25(6): 769-74, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15169630

ABSTRACT

AIM: To study the inhibitory effect of general gambogic acids (GGA) on transplantation tumor SMMC-7721 in experimental animal model and SMMC-7721 cells in vitro. METHODS: Anti-tumor activity of GGA in the experimental transplantation tumor SMMC-7721 was evaluated by relative tumor growth ratio. Cell morphology was observed with inverted microscope and electron microscope. Cell proliferation was measured by MTT assay and the telomerase activity was determined by PCR. RESULTS: In vivo study indicated that GGA (2, 4, and 8 mg/kg, iv, 3 times per week for 3 weeks) displayed an inhibitory effect on the growth of transplantation tumor SMMC-7721 in nude mice compared with the normal saline group (P<0.01). At the concentrations of 0.625-5.0 mg/L, GGA remarkably inhibited the proliferation of SMMC-7721 cells in vitro. GGA 2 mg/L dramatically changed morphology of SMMC-7721 cells and inhibited the telomerase activity in SMMC-7721 cells. CONCLUSION: GGA had inhibitory effect on the growth of SMMC-7721, which might be related to its inhibition of telomerase activity.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Carcinoma, Hepatocellular/pathology , Liver Neoplasms/pathology , Telomerase/metabolism , Xanthones/pharmacology , Animals , Carcinoma, Hepatocellular/enzymology , Carcinoma, Hepatocellular/ultrastructure , Cell Division/drug effects , Cell Line, Tumor , Female , Garcinia/chemistry , Humans , Liver Neoplasms/enzymology , Liver Neoplasms/ultrastructure , Male , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasm Transplantation , Plants, Medicinal/chemistry , Xanthones/isolation & purification
18.
Sichuan Da Xue Xue Bao Yi Xue Ban ; 35(3): 337-9, 2004 May.
Article in Chinese | MEDLINE | ID: mdl-15181829

ABSTRACT

OBJECTIVE: To know whether the essential oil of Artemisia annul L. can induce apoptosis of cultured hepatocarcinoma cell SMMC-7721. METHODS: Hepatocarcinoma cells were treated by the essential oil of Artemisia annul L. while positive control was treated by hydroxycamptothecine (HPT) and negative or mock control was treated by normal saline (NS). Induction of the apoptosis was analyzed by using flow cytometry (FCM), light microscope and electronic microscope, Giemsa's stain and DNA pattern after drug treatment. RESULTS: After the treatment of the cells with 100 micrograms/ml essential oil of Artemisia annul L. for 24 hours, the morphological changes of classic apoptosis such as condensation of cytoplasm, fragmentation of nuclear chromatin, and apoptosis body were seen. The sub-G1 peak was exhibited by FCM, and the DNA ladder pattern was observed. CONCLUSION: These findings demonstrated that the essential oil of Artemisia annul L. could induce apoptosis of cultured SMMC-7721.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , Artemisia annua , Liver Neoplasms/pathology , Oils, Volatile/pharmacology , Artemisia annua/chemistry , Carcinoma, Hepatocellular/pathology , Carcinoma, Hepatocellular/ultrastructure , Drugs, Chinese Herbal/pharmacology , Humans , Liver Neoplasms/ultrastructure , Tumor Cells, Cultured
19.
Zhongguo Zhong Yao Za Zhi ; 29(6): 563-7, 2004 Jun.
Article in Chinese | MEDLINE | ID: mdl-15706925

ABSTRACT

OBJECTIVE: To investigate the anti-cancer activities and the possible mechanism of Chinese herb Dioscrea bulbifera. METHOD: The herb was extracted sequentially with petroleum ether, ethanol and water. The anticancer screen were carried out in vivo with HepA in mice. RESULT: The inhibitory effects on the formation of ascites volume and HepA cell viability in ascites were found in those extracted fractions except water fraction, the petroleum ether fraction being the strongest. Life span of mice bearing HepA ascites was prolonged after exposed to 100 mg x kg(-1) petroleum ether fraction and shortened after exposed to water fraction significantly. Besides, abnormal microstructure on HepA cells surface was found and it was supposed to be potential effect against viability of HepA which was convinced with the regeneration of HepA cells from ascites in mice exposed to petroleum ether fraction. CONCLUSION: Anticancer active compounds are mainly extracted by petroleum ether from hydrophobic constituents of Dioscrea bulbifera and the anticancer effects were related to direct toxicity on tumor cell.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Ascites/pathology , Carcinoma, Hepatocellular/pathology , Dioscorea , Drugs, Chinese Herbal/pharmacology , Liver Neoplasms/pathology , Alkanes , Animals , Antineoplastic Agents, Phytogenic/isolation & purification , Carcinoma, Hepatocellular/ultrastructure , Cell Line, Tumor , Cell Survival/drug effects , Dioscorea/chemistry , Drugs, Chinese Herbal/isolation & purification , Ethanol , Liver Neoplasms/ultrastructure , Male , Mice , Mice, Inbred ICR , Neoplasm Transplantation , Plants, Medicinal/chemistry , Rhizome/chemistry
20.
Orv Hetil ; 142(49): 2741-6, 2001 Dec 09.
Article in Hungarian | MEDLINE | ID: mdl-11883175

ABSTRACT

The clinical history of a 49 year old female patient suggested a multifocal, rapidly progressive liver disease of one month duration, apparently due to metastatic tumour. An open needle biopsy of the liver revealed a primary hepatocellular carcinoma of low grade malignancy; the diagnosis was confirmed by histological, immunohistochemical and electron microscopic studies. Besides the ultrastructural examination of the liver biopsy disclosed an unusually marked proliferation of perisinusoidal (Ito)-cells. The authors assume that the myofibroblast proliferation and transformation of Ito-cells in the noncirrhotic liver led to the formation of multifocal areas. The perisinusoidal cell proliferation was presumably due to vitamin A intoxication caused by an extreme vegetarian diet (daily consumption of large amounts of carrot juice for years, as disclosed by a retrospectively obtained history). It is assumed that the vitamin A abuse, and perisinusoidal cell proliferation may have promoted the unusually rapid progression of the multifocal, but histologically low grade hepatocellular tumour. Spectacular clinical improvement could be observed after chemotherapy, combined with local hyperthermic treatment. Presumably, the change in diet (cessation of excessive retinol and carotene intake) also may have had a beneficial effect. After one year the clinical course suggests a slower progression of tumour growth which would be more in keeping with the prognosis based on the histologic appearance of the low grade hepatocellular carcinoma. This patient's case illustrates the importance of electron microscopy supplementing diagnostic histological and immunohistochemical examinations.


Subject(s)
Carcinoma, Hepatocellular/pathology , Hepatocytes/pathology , Liver Neoplasms/pathology , Carcinoma, Hepatocellular/ultrastructure , Female , Hepatocytes/diagnostic imaging , Humans , Liver Neoplasms/ultrastructure , Microscopy , Microscopy, Electron , Middle Aged , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL